Amisulpride
Amisulpride is a pharmaceutical drug with 36 clinical trials. Historical success rate of 92.6%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
2
Mid Stage
17
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.2%
25 of 29 finished
13.8%
4 ended early
0
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings
An Investigation of Early Life Stress and Depression
Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression
Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
Clinical Trials (36)
Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings
An Investigation of Early Life Stress and Depression
Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression
Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.
Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment
Amisulpride Treatment for BPSD in AD Patients
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
Bergen Psychosis Project 2 - The Best Intro Study
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
The Effects of Dopamine on Reward Processing
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
Pharmacovigilance in Gerontopsychiatric Patients
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 36